These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3783824)

  • 1. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus.
    Underwood PA; Skehel JJ; Wiley DC
    J Virol; 1987 Jan; 61(1):206-8. PubMed ID: 3783824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody.
    Natali A; Oxford JS; Schild GC
    J Hyg (Lond); 1981 Oct; 87(2):185-90. PubMed ID: 7288173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies.
    Yewdell JW; Caton AJ; Gerhard W
    J Virol; 1986 Feb; 57(2):623-8. PubMed ID: 2418215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies.
    Daniels PS; Jeffries S; Yates P; Schild GC; Rogers GN; Paulson JC; Wharton SA; Douglas AR; Skehel JJ; Wiley DC
    EMBO J; 1987 May; 6(5):1459-65. PubMed ID: 3608984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase.
    Laver WG
    Adv Exp Med Biol; 1985; 185():149-74. PubMed ID: 3907308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete mapping of viral escape from neutralizing antibodies.
    Doud MB; Hensley SE; Bloom JD
    PLoS Pathog; 2017 Mar; 13(3):e1006271. PubMed ID: 28288189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic implications of changes in the influenza virus genome.
    Kendal AP
    Am J Med; 1987 Jun; 82(6A):4-14. PubMed ID: 3591816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of antigenic variation in influenza virus.
    Air GM; Laver WG
    Adv Virus Res; 1986; 31():53-102. PubMed ID: 2428216
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses.
    Temoltzin-Palacios F; Thomas DB
    J Exp Med; 1994 May; 179(5):1719-24. PubMed ID: 8163950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of Antigenically Advanced Variants of Influenza Viruses.
    Neumann G; Fan S; Kawaoka Y
    Methods Mol Biol; 2018; 1836():461-486. PubMed ID: 30151587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.
    Okuno Y; Isegawa Y; Sasao F; Ueda S
    J Virol; 1993 May; 67(5):2552-8. PubMed ID: 7682624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antigenic drift in the haemagglutinin molecule of influenza B virus with monoclonal antibodies.
    Webster RG; Berton MT
    J Gen Virol; 1981 Jun; 54(Pt 2):243-51. PubMed ID: 7288409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains.
    Krystal M; Young JF; Palese P; Wilson IA; Skehel JJ; Wiley DC
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4527-31. PubMed ID: 6192436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for host-cell selection of influenza virus antigenic variants.
    Schild GC; Oxford JS; de Jong JC; Webster RG
    Nature; 1983 Jun 23-29; 303(5919):706-9. PubMed ID: 6190093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-haemagglutinin-esterase glycoprotein monoclonal antibodies on the receptor-destroying activity of influenza C virus.
    Hachinohe S; Sugawara K; Nishimura H; Kitame F; Nakamura K
    J Gen Virol; 1989 May; 70 ( Pt 5)():1287-92. PubMed ID: 2471808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on influenza virus. I. Antigenic variation in influenza virus type C.
    Czekalowski JW; Prasad AK
    Arch Gesamte Virusforsch; 1973; 42(3):215-27. PubMed ID: 4796309
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of the erythrocyte receptors for influenza C virus.
    Ohuchi M; Homma M; Muramatsu M; Ohyama S
    Microbiol Immunol; 1978; 22(4):197-203. PubMed ID: 211399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities.
    Daniels RS; Douglas AR; Skehel JJ; Wiley DC; Naeve CW; Webster RG; Rogers GN; Paulson JC
    Virology; 1984 Oct; 138(1):174-7. PubMed ID: 6208680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variation in influenza viruses.
    Air GM; Laver WG; Webster RG
    Contrib Microbiol Immunol; 1987; 8():20-59. PubMed ID: 3304832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.